Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Related BPC-157 Research Compounds Researchers working with the BPC-157 TB-500 blend may also be interested in these related compounds from our catalogue: BPC-157 5mg standalone BPC-157 for isolated single-compound research protocols BPC-157 10mg higher dosage standalone vial for extended research cycles BPC-157 15mg maximum standalone dosage for high-concentration laboratory studies BPC-157 + TB-500 20mg Blend double-strength version of this formulation for extended protocols BPC-157 + TB-500 + GHK-Cu 30mg Glow Blend triple-compound blend adding copper peptide for extracellular matrix research All compounds are independently tested by Janoshik Analytical and supplied with batch-specific COA documentation
Interleukin-27 inhibits herpes simplex virus type 1 infection by activating STAT1 and 3, Interleukin-6, and chemokines IP-10 and MIG
Bioidentical Hormone Replacement Therapy (BHRT) What it Is: BHRT uses hormones that are molecularly identical to the ones your body naturally produces
PMC 4876946
Most existing studies are limited to in vitro or animal models, and data on clinical isolates or patient outcomes are scarce
BDNF/NGF Pathway Enhancers (Lions Mane, 7,8-DHF) Mechanism: These aim to upregulate neurotrophins or mimic TrkB signaling, nudging plasticity
US$ 26.80
US$ 23.21
US$ 29.56
US$ 24.15
US$ 27.97
US$ 24.87
